Industry Trends

March 2020

See what has been happening in Asia’s pharma and personal care industries over the last weeks. What are experts and industry magazines talking about?

What has been happening?

Metformin treatment in children, recovery of haircare from Covid-19, statin use may reduce mortality in high-risk prostate cancer, and more.  Find out what journals and industry experts have been discussing in the last four weeks.

Latest Industry Articles

Metformin Could Reduce Obesity in Children
Drugs.com

Metformin treatment reduces some obesity measures in children, according to a review and meta-analysis published online Feb. 18 in Childhood Obesity.
Read Full Article
Hair care will see quickest recovery from COVID-19 outbreak in China
CosmeticsDesign-Asia

China’s hair care category will bounce back the fastest compared to skin care and colour cosmetics in the aftermath of the novel coronavirus (COVID-19) epidemic, according to a new report.
Read Full Article
Statin Use May Reduce Mortality in High-Risk Prostate Cancer
Drugs.com

Statin use alone or in combination with metformin is associated with lower all-cause and prostate cancer (PCa) mortality among high-risk patients, according to a study.
Read Full Article
Tool Aids Safe Fasting for T2DM Patients Observing Ramadan
Drugs.com

Use of the Fasting Algorithm for Singaporeans with Type 2 Diabetes (FAST) facilitates safe intermittent fasting for patients with diabetes during Ramadan, according to a study.
Read Full Article
2020's hottest sun protection solutions
Cosmetics Business

While new UV absorbers are a rarity, sunscreen manufacturers can mitigate the harmful effects of the sun through clever use of new and existing ingredients, as John Woodruff reports.
Read Full Article
Antibiotics in First Year of Life May Up Risk for T1DM by Age 10
Drugs.com

Antibiotic prescriptions in the first year of life are associated with an increased risk for type 1 diabetes in childhood, according to a study published online March 4 in Diabetes Care.
Read Full Article
Coronavirus Update: FDA Steps to Ensure Quality of Foreign products
Drugs.com

Drugs.com providing updated and more detailed information about the status of FDA inspections in China and the agency’s oversight of imported products from China, which have been impacted by this outbreak.
Read Full Article
Cumulative Dose of Oral Steroids Associated With HTN Incidence
Drugs.com

For adults with any of six chronic inflammatory diseases, a cumulative dose of oral glucocorticoids is associated with an increased incidence of hypertension, according to a study published online March 23 in CMAJ.
Read Full Article
Polymicrobial Phage Library-Based Treatment for Antibiotic-Resistant Infections

Business Wire Health

US FDA has cleared its Investigational New Drug application for the clinical development of PhageBank™, a personalized bacteriophage therapeutic for the treatment of MDR and complicated bacterial infections.

Read Full Article
AAN: Hypersomnolence in Elderly Linked to Medical Conditions
Drugs.com

Hypersomnolence among the elderly is associated with an increased risk for subsequent development of medical conditions, including diabetes, cancer, and hypertension, according to a study.
Read Full Article
Drugmakers tell analyst ingredient prices are rising as FDA reports first supply hit tied to COVID-19
FiercePharma News

The world’s heavy reliance on cheap Chinese ingredients has shown a fault line in the U.S., as the FDA reports the first shortage of a drug due to the COVID-19 outbreak. With 20 other FDA-approved drugs relying solely on China as the source of an API or finished product, more shortages may soon materialize.
Read Full Article
Frustration over alleged slow release of medical supplies
Daily Tribune

The Food and Drugs Administration (FDA) is getting in the way of the Philippines getting more testing kits for the novel coronavirus disease 2019 (COVID-1), a cabinet secretary and a senator said Sunday. Foreign Affairs Secretary Teodoro Locsin Jr. and Senator Panfilo Lacson expressed frustration over the alleged slow release of medical supplies by the Bureau of Customs (BoC) due to the pending approval by the FDA. FDA is an attached agency of the Department of Health (DoH).
Read Full Article

Related Articles & Trends

Pharma & Personal Care Trends – November 2024

Pharma & Personal Care Trends – November 2024

Nov 18, 2024

Beauty 4.0: The state of the menopausal beauty market, New skin care line to address interest in Traditional Chinese Medicine and well-being surges, Benefits of transitioning to E-Cigarettes, and more. See what industry experts have been discussing in the last four weeks.

Pharma & Personal Care Trends – October 2024

Pharma & Personal Care Trends – October 2024

Oct 18, 2024

Sustainable cosmetic packaging innovations at Luxe Pack 2024, One or two-dose HPV vaccination, 3 ways to maintain glowy skin, and more. See what industry experts have been discussing in the last four weeks.

Pharma & Personal Care Trends – September 2024

Pharma & Personal Care Trends – September 2024

Sep 12, 2024

Rutin emerges as a sustainable alternative in sunscreen formulations, Infusing sustainability and transparency into skin care, Formulating menopausal skin care, and more. See what industry experts have been discussing in the last four weeks.

Industry News . Once a month . No spam

Pharmaceuticals

Company

Industries

    Contact Us

    ingredients@jjsea.com

    +66 2787 8787

    Jebsen & Jessen Logo white

    Follow Us